2026-09-22T09:15:57Z https://www.ideals.illinois.edu/oai-pmh

oai:www.ideals.illinois.edu:2142/83635 2023-07-11 col_2142_5131 col_2142_14771 com_2142_5130 com_2142_685 com_2142_397

Kelley, Keith W. Minshall, Christian 2015-09-25T21:08:33Z 2015-09-25T21:08:33Z 10000-01-01 1997 1997 The development of myeloid progenitor cells requires paracrine growth factors to mediate the proliferation, differentiation and survival of these cells. In this thesis, we demonstrate that IGF-I and IL-4, a cytokine produced by activated T-lymphocytes, enhance the survival of CSF-stimulated progenitor cells. One particular enzyme activated by both IGF-I and IL-4 is phosphatidylinositol 3$\sp\prime$-kinase, a lipid kinase which phosphorylates phosphatidylinositol on its 3$\sp\prime$ carbon. We demonstrate that activation of this enzyme is critical for IGF-I- and IL-4-mediated inhibition of apoptosis in CSF-deprived myeloid progenitor cells. Although IL-3 effectively induces PI 3-kinase activity, this is not required for IL-3-stimulated survival of FDCP cells. These data suggest that at least two distinct pathways enhance the survival of myeloid cells, one that is dependent upon PI 3-kinase and one that involves another mechanism. We also clearly demonstrate that the downstream mediator of PI 3-kinase-stimulated survival in IGF-I- and IL-4-treated cells is the anti-apoptotic protein Bcl-2. In IL-3-deprived FDCP cells the levels of Bcl-2 decrease in a time-dependent fashion, and this is negatively correlated with an increase in the apoptotic population of these cells. Treatment of IL-3-deprived FDCP cells with IGF-I or IL-4 increases the expression of Bcl-2 protein relative to cells incubated in medium alone. This enhanced expression of Bcl-2 is dependent upon IGF-I- or IL-4-activated PI 3-kinase. Treatment of these cells with either wortmannin or LY294002, two potent inhibitors of PI 3-kinase activity, abrogates the ability of IGF-I or IL-4 to maintain the expression of Bcl-2 in FDCP cells. As expected neither inhibitor affected the ability of IL-3 to maintain Bcl-2 expression or inhibit apoptosis. These data confirm our initial findings which demonstrate that two distinct ligand-dependent mechanisms are involved in mediating the survival of myeloid progenitor cells. We also demonstrate that S6-kinase, an enzyme which mediates the downstream proliferative signal of PI 3-kinase, does not transduce IGF-I- or IL-4-stimulated inhibition of apoptosis. The expression of the pro-apoptotic protein, Bax, does not change even after IL-3 withdrawal for 24 h, and is not regulated by IL-3, IGF-I or IL-4 in the presence or absence of PI 3-kinase inhibitors. These data confirm previous studies that demonstrate cell survival is regulated by relative Bcl-2 and Bax ratios. Collectively, these data demonstrate that IGF-I and IL-4 enhance myeloid cell survival by increasing the expression of Bcl-2 via activation of PI 3-kinase, while IL-3 utilizes an alternative signaling pathway. Made available in DSpace on 2015-09-25T21:08:33Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 9737202.pdf: 7782978 bytes, checksum: 91dff138b2c1f47cc1ed89a3660b466a (MD5) Previous issue date: 1997 Embargo set by: Seth Robbins for item 84916 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs U of I Only 176 p. Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1997. http://hdl.handle.net/2142/83635 (MiAaPQ)AAI9737202 eng Biology, Cell The Role of Igf-1 and Il-4 in Myeloid Progenitor Cell Survival text Animal Sciences Animal Sciences University of Illinois at Urbana-Champaign Dissertation Ph.D.